Repligen (United States)
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Repligen (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
42%
Total
Publications
204
Total Open
Publications
85
Total
Citations
7.3K
Open Access
Percentage
42%
Total
Publications
204
Total Open
Publications
85
Total
Citations
7.3K
Breakdown
Publisher Open
11%
Both
17%
Other Platform Open
12%
Closed
60%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
20
Hybrid 23%
13
No Guarantees 41%
23
Other Platform Open
Domain 60%
36
Other Internet 25%
15
Preprint 20%
12
Public 8%
5
Institution 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 36 |
DOI | Other Internet | 16 |
bioRxiv | Preprint | 8 |
Figshare | Public | 5 |
Europe PMC | Domain | 4 |
medRxiv | Preprint | 3 |
Université Libre de Bruxelles | Institution | 1 |
Royal Netherlands Academy of Arts and Sciences | Institution | 1 |
Preprints | Preprint | 1 |
Harvard University | Institution | 1 |